跳至主要内容
临床试验/NCT06927700
NCT06927700已完成不适用

Effects of FDA Authorized Smokeless Tobacco Claims Among US Adults Who Smoke Cigarettes

Rutgers, The State University of New Jersey1 个研究点 分布在 1 个国家目标入组 1,257 人开始时间: 2025年4月24日最近更新:
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
1,257
试验地点
1
主要终点
Product Use Intentions

研究概览

简要总结

This study will be an online survey experiment conducted with adults who smoke cigarettes (ages 21+) to examine their reactions to modified risk advertising claims authorized by the Food & Drug Administration (FDA) for two smokeless tobacco brands (General Snus and Copenhagen), which describe the lower risks of these products compared to cigarette smoking. The study will compare effects of ads with different two different claim types (i.e. claims about reduced lung cancer risk and claims about reduced risks for multiple disease) versus ads with no reduced-risk claims, and examine effects on message and product perceptions, and interest in using the smokeless tobacco products. This study will also examine how smokers' reactions/interest may vary based on the product brand, and asses prior awareness/exposure to the authorized claims.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults (age 21 and over) who are current established cigarettes smokers (i.e., smoked 100 cigarettes in their lifetime and now smoke every day or somedays), based in the US, members of Ipsos' KnowledgePanel, and have chosen to complete their research panel surveys in English

排除标准

  • Panel participants who do not meet the criteria outlined above will be excluded.

研究组 & 干预措施

Group 1 (General Snus-Control Ads)

Other

Participants in this group will view 4 ads for the brand General Snus that do not include a modified risk claim.

干预措施: Modified Risk Claim Type - None (Behavioral)

Group 1 (General Snus-Control Ads)

Other

Participants in this group will view 4 ads for the brand General Snus that do not include a modified risk claim.

干预措施: Product Brand - General Snus (Behavioral)

Group 2 (General Snus-Multiple Disease Ads)

Experimental

Participants in this group will view 4 ads for the brand General Snus that include a modified risk claim about the lower risk of multiple diseases.

干预措施: Product Brand - General Snus (Behavioral)

Group 2 (General Snus-Multiple Disease Ads)

Experimental

Participants in this group will view 4 ads for the brand General Snus that include a modified risk claim about the lower risk of multiple diseases.

干预措施: Modified Risk Claim Type - Multiple Diseases (Behavioral)

Group 3 (General Snus- Lung Ads)

Experimental

Participants in this group will view 4 ads for the brand General Snus that include a modified risk claim about the lower risk of lung cancer only.

干预措施: Product Brand - General Snus (Behavioral)

Group 3 (General Snus- Lung Ads)

Experimental

Participants in this group will view 4 ads for the brand General Snus that include a modified risk claim about the lower risk of lung cancer only.

干预措施: Modified Risk Claim Type - Lung Cancer (Behavioral)

Group 4 (Copenhagen-Control Ads)

Experimental

Participants in this group will view 4 ads for the brand Copenhagen that do not include a modified risk claim.

干预措施: Modified Risk Claim Type - None (Behavioral)

Group 4 (Copenhagen-Control Ads)

Experimental

Participants in this group will view 4 ads for the brand Copenhagen that do not include a modified risk claim.

干预措施: Product Brand - Copenhagen (Behavioral)

Group 5 (Copenhagen-Multiple Disease Ads)

Experimental

Participants in this group will view 4 ads for the brand Copenhagen that include a modified risk claim about the lower risk of multiple diseases.

干预措施: Product Brand - Copenhagen (Behavioral)

Group 5 (Copenhagen-Multiple Disease Ads)

Experimental

Participants in this group will view 4 ads for the brand Copenhagen that include a modified risk claim about the lower risk of multiple diseases.

干预措施: Modified Risk Claim Type - Multiple Diseases (Behavioral)

Group 6 (Copenhagen- Lung Ads)

Experimental

Participants in this group will view 4 ads for the brand Copenhagen that include a modified risk claim about the lower risk of lung cancer only.

干预措施: Product Brand - Copenhagen (Behavioral)

Group 6 (Copenhagen- Lung Ads)

Experimental

Participants in this group will view 4 ads for the brand Copenhagen that include a modified risk claim about the lower risk of lung cancer only.

干预措施: Modified Risk Claim Type - Lung Cancer (Behavioral)

结局指标

主要结局

Product Use Intentions

时间窗: Assessed in survey measures completed immediately after viewing the study stimuli

Assessment of intentions to use the viewed smokeless tobacco products based on averaging responses to three parallel questions: "Thinking about the ads you saw for \[General Snus or Copenhagen\] products, how interested, in the next 6 months, would you be in: 1) Using or trying these products? 2) Using these products as a way to quit or cut down on your cigarette smoking? 3) Completely switching from cigarettes to these products? Response options to each were on a 5 point scale from (1=not at all interested to 5=extremely interested). Results presented here are based on the averaged responses to these three items. Higher scores mean greater interest in using the products.

General Relative Harm Perception

时间窗: Assessed in survey measures completed immediately after viewing the study stimuli

Single item measure asking participants how harmful they think daily use of the viewed smokeless tobacco product would be to their health compared to daily cigarette smoking, (1=a lot less harmful, 2=somewhat less harmful, 3=about the same, 4=somewhat more harmful, 5=a lot more harmful). Higher scores mean thinking the viewed smokeless tobacco product is more harmful than cigarettes.

Perceptions of Perceived Relative Risks of Diseases

时间窗: Assessed in survey measures completed immediately after viewing the study stimuli

Assessment of perceived risks of getting various smoking related diseases from using the viewed smokeless tobacco product versus from smoking cigarettes. Responses to 6 parallel questions (each asking about a different disease) were averaged together in this composite item. The question stated: "If you used only \[General Snus/Copenhagen - inserted based on brand condition\] or only cigarettes every day, which product would make it more likely that you would get": 1) lung cancer; 2) heart disease; 3) mouth cancer; 4) stroke; 5) chronic bronchitis; 6) emphysema. Response options to each were on a 5 point scale from (1=much more likely with General Snus/Copenhagen to 5=much more likely with cigarettes). Results presented here are based on the averages responses to the six items. Higher scores mean thinking risks are greater from smoking cigarettes than from using the viewed smokeless tobacco product.

Absolute Harm Perception

时间窗: Assessed in survey measures completed immediately after viewing the study stimuli

Single item measure asking participants how likely or unlikely they think the viewed smokeless tobacco product would be to cause serious health problems during their lifetime, if they used it every day (from 1=not at all likely to 5=extremely likely). Higher scores mean greater likelihood of thinking the product is harmful to health.

次要结局

  • Risk Message Recall(Assessed in survey measures completed immediately after viewing the study stimuli)
  • Ad Persuasiveness(Assessed in survey measures completed immediately after viewing the study stimuli)
  • Claim Believability & Credibility(Assessed in survey measures completed immediately after viewing the study stimuli)
  • Overall Perceived Claim Persuasiveness(Assessed in survey measures completed immediately after viewing the study stimuli)
  • Switching Comprehension(Assessed in survey measures completed immediately after viewing the study stimuli)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Olivia A. Wackowski, PhD, MPH

Associate Professor

Rutgers, The State University of New Jersey

研究点 (1)

Loading locations...

相似试验